Cefaclor
Cefaclor is a premium-grade, white to off-white crystalline powder second-generation cephalosporin antibiotic compound carrying CAS number 53994-73-3. Processed under strict pharmaceutical compliance, this high-purity beta-lactam active substance exhibits exceptional bacterial cell wall synthesis inhibition efficiency and reliable matrix stability, making it an ideal core choice for manufacturing clinical-strength pediatric oral suspensions, advanced anti-infective capsules, and modern pharmacological research lines globally.
Description
Zyntex supplies high-purity Cefaclor (CAS 53994-73-3) tailored specifically for global pharmaceutical manufacturing plants, infectious disease research laboratories, and international organic synthesis loops.
Functioning as a highly specific penicillin-binding protein (PBP) inhibitor and cell wall synthesis terminator, it delivers precise substance profiles that ensure uniform dry batch integration and highly predictable dissolution kinetics in solid-dose manufacturing matrices. Furthermore, its strictly minimized chemical volatile impurities and optimized crystal particle size geometry make it an ideal selection for sensitive oral capsule and granulated suspension production. Accordingly, formulation scientists specify this active substance to stabilize modern beta-lactam carriers and maintain exact potency integrity across continuous processing cycles.
Bacterial Cell Wall Inhibition and Matrix Granulation Stability
Excellent crystalline density distribution and outstanding intracellular molecular binding affinity provide a distinct operational edge when engineering modern fast-acting antimicrobial formulations. This active pharmaceutical solid operates by disrupting the cross-linking of peptidoglycan polymers to break down pathogen defense setups, supplying the exact chemical mechanisms required to induce rapid bacterial lysis without altering raw pharmaceutical binder uniformity. It assists compounding engineers in maintaining strict dosage uniformity across high-speed tablet compression and capsule filling lines, mitigating trace instability risks within automated volumetric dosing machinery. For instance, specialized pharmaceutical facilities incorporate this second-generation antibiotic powder as a core active component in targeted upper respiratory anti-infective production. As a consequence, it maximizes the technical throughput of automated filling machinery and continuous quality assurance checks. Consequently, Zyntex coordinates clean room crystallization paths to eliminate downstream polymorph shifts from your factory schedule.
In addition to this, Zyntex coordinates climate-controlled logistics for pilot-scale trials and advanced infectious disease drug research centers. The compound maintains its refined crystalline integrity under strict storage parameters, preventing heat-induced chemical breakdown or structural degradation during automated mechanical blending steps. It advances contemporary medical engineering by providing a thoroughly analyzed, highly predictable antibacterial raw material that meets international monograph standards. Simultaneously, it remains a critical chemical standard for routine high-performance liquid chromatography (HPLC) compound calibration assays and microbiological zone-of-inhibition testing validation loops. In brief, our product functions as a dependable chemical foundation, supporting both the performance of commercial clinical batches and the analytical rigor of specialized industrial laboratories.
Primary Medical Sectors for Cefaclor
This high-purity crystalline active drug compound delivers crucial technical value within these four primary industrial sectors:
💊 Antibiotic Capsules
Primary antimicrobial hammadde source used for formulating uniform, high-bioavailability oral solid capsules. Hence, it directly supports optimal absorption control lines.
🧪 Pediatric Suspensions
Utilized as a stable crystalline active base to compound reconstitutable dry syrup formulations and oral granules. Clearly, it is key for uniform dissolving patterns.
🔬 Susceptibility Bioassays
Acts as an essential reference active standard for monitoring cephalosporin resistance metrics, assay calibration, and routine laboratory diagnostics. Resultantly, it guarantees excellent matrix clarity.
🏢 Resistance Research
Used as a professional active component for validating advanced beta-lactamase degradation models and specialized liposomal drug carriers. Specifically, it confirms optimal reaction pathways.
Technical Specifications
| Parameter | Standard Value |
|---|---|
| Product Name | Cefaclor Anhydrous / Monohydrate |
| Assay / Purity (HPLC) | 96.0% to 102.0% (Anhydrous Basis) |
| Appearance | White to slightly yellowish crystalline powder |
| Specific Rotation | +101.0° to +111.0° |
| Solubility | Slightly soluble in water; practically insoluble in methanol and chloroform |
| CAS Number | 53994-73-3 (Anhydrous) / 70356-03-5 (Monohydrate) |
⚠️ Safety & Handling (BETA-LACTAM SENSITIZER): Cefaclor is an active cephalosporin antibiotic pharmaceutical active ingredient. Direct inhalation of crystalline bulk powder dust or accidental transdermal/ocular exposure poses a moderate risk of localized respiratory tract sensitization, occupational skin rashes, and potential allergic hypersensitivity responses in individuals sensitive to beta-lactam compounds. Therefore, store strictly inside original double-sealed airtight industrial containers within a cool, exceptionally dry, and secure pharmaceutical warehouse zone isolated from volatile moisture sources and direct flame risks. Prevent airborne dust clouds during dispensing setups. Proper personal protective equipment (PPE)—including high-grade chemical-resistant gloves, protective safety goggles, and a certified clinical dust respirator mask—must be worn during all manufacturing handling phases. Review the Safety Data Sheet (SDS).
